A Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by a Reduced Intensity Conditioning Allogeneic Stem-Cell Transplantation for Patients with Refractory leukemia.

Authors

Usama Gergis MD, MBA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2010

Volume

116

Issue

21

Published In/Presented At

https://doi.org/10.1182/blood.V116.21.1334.1334

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article